$0.215
-0.022[-9.28%]
At close: Jun 7
$0.215
0[0.00%]
After Hours: 7:44PM EDT
Apollomics
(NASDAQ:APLM)Latest News for Apollomics Stock (NASDAQ:APLM)
Apollomics Stock (NASDAQ: APLM)
Categories: All
Tuesday, June 04, 2024
Wednesday, May 29, 2024
Wednesday, May 08, 2024
- Apollomics Announces ~$6M Private Placement Financing; Pursuant To The Terms Of The Subscription Agreements, Co Is Selling An Aggregate Of 19,166,666 Class A Ordinary Shares At A Price Of $0.30/ShareBenzinga Newsdesk
- HC Wainwright & Co. Maintains Buy on Apollomics, Lowers Price Target to $2Benzinga Newsdesk
Thursday, April 25, 2024
Monday, April 01, 2024
- Apollomics Inc Files For Mixed Shelf Of Up To $200MBenzinga Newsdesk
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights
- EF Hutton Maintains Buy on Apollomics, Lowers Price Target to $6.5Benzinga Newsdesk
- HC Wainwright & Co. Maintains Buy on Apollomics, Lowers Price Target to $5Benzinga Newsdesk
Thursday, March 28, 2024
Tuesday, March 26, 2024
Monday, March 04, 2024
Wednesday, February 07, 2024
Tuesday, February 06, 2024
Friday, January 19, 2024
Tuesday, January 09, 2024
Wednesday, January 03, 2024
Monday, December 04, 2023
Thursday, November 30, 2023
Monday, November 27, 2023
- Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin
- Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving PremarketLisa Levin
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights
Wednesday, November 22, 2023
Monday, November 20, 2023
Thursday, November 16, 2023
- Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin
- Why Is Cancer Firm Apollomics Stock Trading Higher Today?Vandana Singh
- US Stocks Down; Jobless Claims Rise To 231,000Lisa Levin
- Market-Moving News for November 16thBenzinga Newsdesk
- Apollomics Announces The First Approval Of Vebreltinib For MET Exon 14 Skip Non-Small Cell Lung CancerBenzinga Newsdesk
Tuesday, October 31, 2023
Friday, October 27, 2023
- Apollomics shares are trading higher. The company yesterday announced a report on the efficacy response of a patient treated with vebreltinib for GBM with PTPRZ-MET fusion.Benzinga Newsdesk
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights
- Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin
- What's Going On With Apollomics Inc Stock?Erica Kollmann
- Apollomics Shares Resume TradeBenzinga Newsdesk
- Nasdaq Jumps 100 Points; Amazon Posts Upbeat EarningsLisa Levin
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights
- Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketLisa Levin
Thursday, October 26, 2023
Monday, October 23, 2023
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights
- Crude Oil Falls Sharply; Apollomics Shares PlungeLisa Levin
- Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights
- Nasdaq Turns Higher; Akumin Shares JumpLisa Levin
- Apollomics shares are trading lower after the company announced the presentation of vebreltinib efficacy and safety data from the KUNPENG clinical trial at ESMO 2023.Benzinga Newsdesk
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights
- Market-Moving News for October 23rdBenzinga Newsdesk
- Apollomics Announces Efficacy Of Vebreltinib In NSCLC Patients With MetEx14 Skipping Mutation Achieving An Overall Response Rate Of 75%Benzinga Newsdesk